在全身治疗的新时代，我们如何使用肝动脉灌注化疗？ - Suppr

Suppr

超能文献

How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?

作者信息

Ogasawara Sadahisa, Kanogawa Naoya, Kato Naoya

机构信息

Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

Hepatobiliary Surg Nutr. 2022 Oct;11(5):775-778. doi: 10.21037/hbsn-22-396.

DOI:10.21037/hbsn-22-396

PMID:36268255

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9577980/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abc/9577980/e9843c077473/hbsn-11-05-775-f1.jpg

相似文献

How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?在全身治疗的新时代，我们如何使用肝动脉灌注化疗？

Hepatobiliary Surg Nutr. 2022 Oct;11(5):775-778. doi: 10.21037/hbsn-22-396.

Therapeutic strategy for postoperative liver metastasis from esophageal squamous cell carcinoma; clinical efficacy of and problem with hepatic arterial infusion chemotherapy.食管鳞状细胞癌术后肝转移的治疗策略；肝动脉灌注化疗的临床疗效及问题

Hepatogastroenterology. 2001 Nov-Dec;48(42):1652-5.

Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study.肝动脉灌注化疗联合瑞戈非尼治疗晚期结直肠癌：一项真实世界的回顾性研究。

BMC Gastroenterol. 2022 Jul 4;22(1):328. doi: 10.1186/s12876-022-02344-4.

[Extra- and intra-hepatic metastasis successfully treated with alternative chemotherapy with hepatic arterial infusion and systemic intravenous infusion after responding to hepatic metastasis from colon cancer by hepatic arterial infusion--a case report].[经肝动脉灌注化疗对结肠癌肝转移有效后，采用肝动脉灌注与全身静脉输注交替化疗成功治疗肝内及肝外转移——病例报告]

Gan To Kagaku Ryoho. 2007 Nov;34(12):1976-8.

Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.经肝动脉灌注化疗泵治疗结直肠癌肝转移：新时代的老技术。

Curr Oncol. 2014 Feb;21(1):e116-21. doi: 10.3747/co.21.1592.

Arterial chemotherapy in the management of colorectal cancer: an overview.

Semin Oncol. 1991 Oct;18(5):478-90.

[A case report-advanced pancreas cancer with liver and lung metastases well controlled over one year by combination therapy with systemic chemotherapy, radiation and hepatic arterial infusion in an outpatient setting].[一例晚期胰腺癌伴肝肺转移患者在门诊通过全身化疗、放疗和肝动脉灌注联合治疗实现病情良好控制超过一年的病例报告]

Gan To Kagaku Ryoho. 2008 Nov;35(12):2117-9.

Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases.肝动脉灌注与全身化疗联合治疗伴有同步肝转移的胃癌

Jpn J Surg. 1984 Jan;14(1):23-9. doi: 10.1007/BF02469598.

[Pharmacokinetics of "subselective" arterial infusion chemotherapy].["亚选择性"动脉灌注化疗的药代动力学]

Gan To Kagaku Ryoho. 2001 Oct;28(11):1795-8.

Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patients.胃癌肝转移的肝动脉灌注化疗：西方患者的分析

Tumori. 2011 Jan-Feb;97(1):19-24. doi: 10.1177/030089161109700104.

引用本文的文献

The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study.肱动脉途径在肝动脉灌注化疗治疗中的可行性和安全性：一项回顾性研究。

J Gastrointest Oncol. 2023 Aug 31;14(4):1830-1836. doi: 10.21037/jgo-23-523. Epub 2023 Aug 30.

本文引用的文献

Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).奥沙利铂联合氟尿嘧啶与索拉非尼治疗晚期肝细胞癌的动脉化疗：一项生物分子探索性、随机、III 期试验（FOHAIC-1）。

J Clin Oncol. 2022 Feb 10;40(5):468-480. doi: 10.1200/JCO.21.01963. Epub 2021 Dec 14.

Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice.采用FOLFOX方案经动脉灌注化疗治疗晚期肝细胞癌：一项多中心倾向评分匹配的真实世界实践分析

Hepatobiliary Surg Nutr. 2021 Oct;10(5):631-645. doi: 10.21037/hbsn.2020.03.14.

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.奥沙利铂、氟尿嘧啶和亚叶酸钙肝动脉灌注与经动脉化疗栓塞治疗大肝细胞癌的随机III期试验

J Clin Oncol. 2022 Jan 10;40(2):150-160. doi: 10.1200/JCO.21.00608. Epub 2021 Oct 14.

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.肝动脉灌注化疗对比索拉非尼治疗局部进展期肝细胞癌的生存获益

Cancers (Basel). 2021 Feb 5;13(4):646. doi: 10.3390/cancers13040646.

Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials.在设计临床试验之前对接受经动脉化疗栓塞术的中期肝细胞癌患者进行的分析。

Liver Cancer. 2020 Sep;9(5):596-612. doi: 10.1159/000508809. Epub 2020 Jul 22.

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.肝动脉灌注化疗与索拉非尼治疗晚期肝细胞癌的疗效比较

Liver Cancer. 2020 Sep;9(5):583-595. doi: 10.1159/000508724. Epub 2020 Jul 24.

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.乐伐替尼用于超出七项标准且肝功能为Child-Pugh A级的中期肝细胞癌患者的初始治疗：一项概念验证研究。

Cancers (Basel). 2019 Jul 31;11(8):1084. doi: 10.3390/cancers11081084.

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.索拉非尼联合奥沙利铂、氟尿嘧啶和亚叶酸治疗伴有门静脉侵犯的肝细胞癌与索拉非尼单药治疗的随机临床试验。

JAMA Oncol. 2019 Jul 1;5(7):953-960. doi: 10.1001/jamaoncol.2019.0250.

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.索拉非尼联合低剂量顺铂和氟尿嘧啶肝动脉灌注化疗与索拉非尼单药治疗晚期肝细胞癌的随机、开放标签、3 期试验（SILIUS）

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7.

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.不可切除肝细胞癌患者的动脉栓塞或化疗栓塞与对症治疗对比：一项随机对照试验

Lancet. 2002 May 18;359(9319):1734-9. doi: 10.1016/S0140-6736(02)08649-X.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验